Concepedia

RETRACTED: Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis

Fatemeh Khaki‐Khatibi, Marjan Ghorbani, Mehdi Sabzichi, Fatemeh Ramezani, Jamal Mohammadian

Biomedicine & Pharmacotherapy · 2018 · 29 citations · 27 references

DOIFull text

Open access

References

27

Doxorubicin pathways

Caroline F. Thorn, Connie Oshiro, Sharon Marsh et al. · Pharmacogenetics and Genomics · 2010 · 1.6K citations · Full text

, , +6

Stattic: A Small-Molecule Inhibitor of STAT3 Activation and Dimerization

Jochen Schust, Bianca Sperl, Angela Hollis et al. · Chemistry & Biology · 2006 · 1.1K citations

, , +5

MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs <i>In vitro</i> and <i>In vivo</i>

Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru et al. · Molecular Cancer Therapeutics · 2010 · 926 citations · Full text

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

David Miles, Arlene Chan, Luc Dirix et al. · Journal of Clinical Oncology · 2010 · 881 citations

Stat proteins and oncogenesis

Jacqueline Bromberg · Journal of Clinical Investigation · 2002 · 676 citations

, , +16